CSE:MBAI - Post Discussion
Post by
MarketMakerss on Dec 20, 2023 5:29pm
Strengthened Ties
Deepening its ties with Yale University, MedBright AI (MBAI.c MBAIF) has unveiled CareMEDICA, a Yale University School of Medicine affiliated clinic group, as a beta customer for its AI-driven data and analytics platform, MedMatrix!
CareMEDICA, MBAI's second beta customer, is a leading provider of primary care services for patients throughout Connecticut and the South Florida region. Focused on a more personal approach to healthcare, CareMEDICA leverages AI as a tool to help improve clinical efficiency and process data faster as detailed by Fausto Petruzziello, MD, Medical Director of CareMEDICA when commenting about the positive outcomes he expects MedMatrix to provide.
MedMatrix, MBAI's industry-leading AI-powered data analytics platform, leverages artificial intelligence to assess crucial aspects of healthcare facilities to drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic, while reducing physician burnout and improving patient satisfaction.
This announcement follows closely on the heels of MBAI's inaugural beta customer, the Dermatology Institute & Skin Scare Center, a leader in dermatologic services in Southern California, who additionally chose to implement MedMatrix to improve their clinic operations.
AI's ability to be "one of the most impactful technology drivers in almost every aspect of our lives" has catapulted MBAI into a unique position, achieving milestones that are rare for small-cap companies such as the appointment of two US healthcare experts to its Board of Directors, including a Professor of Medicine at Yale Medical School, as well as their participation in the Ken Sperling Lecture Series, a series of medical economics lectures at Yale University School of Medicine.
Notably, very few emerging tech and small-cap companies have such strong connections to Yale as only "companies with credibility, relationships and something important do" are on their radar, emphasizing the significance here. Notably, MBAI's Investment Chair, Michael Dalsin, has his own significant relationship with Yale, strengthening this partnership.
Posted on Behalf of MedBright AI Investments Inc.
Be the first to comment on this post